Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (scFv-CH1/CL) (BSCC-160)

Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-FGF2 antibody variable domain is fused to CH1 and the other scFv from an anti-VEGF antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer therapy.

Datasheet INQUIRY

Specifications

Targets

FGF2 & VEGF

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer

Targets

Target 1

FGF2

Gene ID

2247

UniProt ID

P09038

Alternative Names

FGF; Fibroblast growth factor; FGF2; fibroblast growth factor 2; BFGF; FGFB; FGF-2; HBGF-2

Target 2

VEGF

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (scFv-CH1/CL) (BSCC-160). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-160)

Specifications

Targets

Customer Reviews and Q&As